The 2019 National University of Singapore (NUS) Initiative to Improve Health in Asia Leadership Development Programme (NIHA LDP) was held at NUS, Singapore from the 24th – 29th June. The event aimed to equip policy-makers with an understanding of  health technology assessment (HTA) for health care p

Partners from the International Decision Support Initiative (iDSI) join the 2nd China Health Technology Assessment Conference organised by the China National Health Development Research Center (CNHDRC) on 26-27 October 2019 in Beijing, China. The event brings together China’s high-level representati

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e

As we approach the end of an unprecedented year, the approval of select COVID-19 vaccines by stringent regulatory authorities and programmatic roll-out has been cause for optimism. However, it is imperative to assure equitable access to those in need in all regions of the world as a core component o

In the late year of 2020, the COVID-19 vaccines in the news which claim itself for possessing 90% efficacy seems to be the light at the end of the tunnel for all population in the world. All eyes are being kept on the upcoming promising vaccines while ones with lower efficacy are seen scept

To support government decision-making to address the COVID-19 outbreak, the National Data Management Center (NDMC) of the Ethiopia Public Health Institute (EPHI) conducted a systematic review of the economic evaluations of public health measures for the prevention and control of pandemics. The study

Vaccines have been a game-changer in the fight against COVID-19. Yet, vaccine hesitancy has impeded its uptake, impacting public health efforts. At the outset of the pandemic, people had doubts about this unfamiliar virus and subsequently, the vaccine: misinformation, rumours, and doubts about COVID

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the

Asst. Prof Hannah Clapham during the policy conference session “Charting a path to sustainable immunization programs and preparedness/response strategies” The development, delivery, access, and perceptions around vaccination were all significantly impacted by pandemics. The pand